Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis. Versteegh M Pharmacoeconomics. 2016 Jun 9. PMID: 27282692. Abstract CommentRecommendBookmarkWatch
